If clinical trials continue to show that psychedelics offer safe and long-lasting results, then psychedelic-assisted therapy could flourish as a treatment in the mental health space.
Mark Bleackley, PhD, discusses the upcoming phase 2 trial of IHL-675A designed to explore arthritis treatment through dual-drug comparison, promising global expansion, and its impact on patients’ pain relief.
OSA pharmacotherapy reduces disease severity healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Item 4.01 Changes in Registrant s Certifying Accountant. Following completion of the Scheme of Arrangement between Incannex Healthcare Limited and Incannex Healthcare Inc..